Professor Berwanger (MD; PhD) is a cardiologist and clinical trialist who has been working as Chair of the Executive and Steering Committees and Global Study Director of large-scale randomized clinical trials. Dr Berwanger also created and coordinates a network of 92 Hospitals in Brazil to conduct COVID-19 trials.
Professor Berwanger is currently the Director of the largest clinical trials unit and coordinating center in Latin America (the Academic Research Organization- ARO, of the Hospital Israelita Albert Einstein) in Sao Paulo-SP, Brazil. Hospital Israelita Albert Einstein is the leading hospital (#1) in Latin America and the #34 best hospital in the World according to Newsweek 2020. He was the main presenter of over 12 large clinical trials in late-breaking clinical trial sessions at the American College of Cardiology Scientific Sessions, American Heart Association Scientific Sessions and European Congress of Cardiology-ESC. Professor Berwanger has published manuscripts in major medical journals such as New England Journal of Medicine, Lancet, JAMA, Circulation, JACC, Annals of Internal Medicine, BMJ, and the European Heart Journal. Besides the design and coordination of large-scale trials.
